These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10480664)

  • 1. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients.
    Braus DF; Ende G; Weber-Fahr W; Sartorius A; Krier A; Hubrich-Ungureanu P; Ruf M; Stuck S; Henn FA
    Schizophr Res; 1999 Aug; 39(1):19-29. PubMed ID: 10480664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication.
    Wenz F; Schad LR; Knopp MV; Baudendistel KT; Flömer F; Schröder J; van Kaick G
    Magn Reson Imaging; 1994; 12(7):975-82. PubMed ID: 7997102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical response to motor stimulation in neuroleptic-naive first episode schizophrenics.
    Braus DF; Ende G; Hubrich-Ungureanu P; Henn FA
    Psychiatry Res; 2000 May; 98(3):145-54. PubMed ID: 10821997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging.
    Schröder J; Wenz F; Schad LR; Baudendistel K; Knopp MV
    Br J Psychiatry; 1995 Aug; 167(2):197-201. PubMed ID: 7582669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging.
    Schröder J; Essig M; Baudendistel K; Jahn T; Gerdsen I; Stockert A; Schad LR; Knopp MV
    Neuroimage; 1999 Jan; 9(1):81-7. PubMed ID: 9918729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study.
    Payoux P; Boulanouar K; Sarramon C; Fabre N; Descombes S; Galitsky M; Thalamas C; Brefel-Courbon C; Sabatini U; Manelfe C; Chollet F; Schmitt L; Rascol O
    Mov Disord; 2004 Jan; 19(1):83-90. PubMed ID: 14743365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine.
    Bertolino A; Blasi G; Caforio G; Latorre V; De Candia M; Rubino V; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Biol Psychiatry; 2004 Aug; 56(3):190-7. PubMed ID: 15271588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.
    Juckel G; Schlagenhauf F; Koslowski M; Filonov D; Wüstenberg T; Villringer A; Knutson B; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2006 Aug; 187(2):222-8. PubMed ID: 16721614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
    Honey GD; Bullmore ET; Soni W; Varatheesan M; Williams SC; Sharma T
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13432-7. PubMed ID: 10557338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study.
    Machielsen MW; Veltman DJ; van den Brink W; de Haan L
    J Psychopharmacol; 2014 Jul; 28(7):633-42. PubMed ID: 24646809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
    Meisenzahl EM; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):522-31. PubMed ID: 17151834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clozapine on motor function in schizophrenic patients.
    Vrtunski PB; Konicki PE; Kwon KY; Jurjus G; Jaskiw GE
    Schizophr Res; 1996 May; 20(1-2):187-98. PubMed ID: 8794509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional magnetic resonance imaging of motor cortex activation in schizophrenia.
    Lee HJ; Preda A; Ford JM; Mathalon DH; Keator DB; van Erp TG; Turner JA; Potkin SG
    J Korean Med Sci; 2015 May; 30(5):625-31. PubMed ID: 25931795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI.
    Northoff G; Braus DF; Sartorius A; Khoram-Sefat D; Russ M; Eckert J; Herrig M; Leschinger A; Bogerts B; Henn FA
    Psychol Med; 1999 Jul; 29(4):997-1002. PubMed ID: 10473328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.
    Müller JL; Deuticke C; Putzhammer A; Röder CH; Hajak G; Winkler J
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):562-8. PubMed ID: 14629703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients.
    Molina V; Tamayo P; Montes C; De Luxán A; Martin C; Rivas N; Sancho C; Domínguez-Gil A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):948-54. PubMed ID: 18262704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.